Information between 14th November 2021 - 11th August 2024
Note: This sample does not contain the most recent 2 weeks of information. Up to date samples can only be viewed by Subscribers.
Click here to view Subscription options.
Division Votes |
---|
22 Jul 2024 - Economy, Welfare and Public Services - View Vote Context Peter Swallow voted No - in line with the party majority and in line with the House One of 377 Labour No votes vs 0 Labour Aye votes Tally: Ayes - 111 Noes - 390 |
23 Jul 2024 - Immigration and Home Affairs - View Vote Context Peter Swallow voted No - in line with the party majority and in line with the House One of 373 Labour No votes vs 0 Labour Aye votes Tally: Ayes - 85 Noes - 382 |
23 Jul 2024 - Immigration and Home Affairs - View Vote Context Peter Swallow voted No - in line with the party majority and in line with the House One of 361 Labour No votes vs 7 Labour Aye votes Tally: Ayes - 103 Noes - 363 |
23 Jul 2024 - Immigration and Home Affairs - View Vote Context Peter Swallow voted No - in line with the party majority and in line with the House One of 374 Labour No votes vs 0 Labour Aye votes Tally: Ayes - 117 Noes - 384 |
25 Jul 2024 - Criminal Law - View Vote Context Peter Swallow voted Aye - in line with the party majority and in line with the House One of 312 Labour Aye votes vs 0 Labour No votes Tally: Ayes - 323 Noes - 81 |
29 Jul 2024 - Passenger Railway Services (Public Ownership) Bill - View Vote Context Peter Swallow voted Aye - in line with the party majority and in line with the House One of 341 Labour Aye votes vs 0 Labour No votes Tally: Ayes - 351 Noes - 84 |
Speeches |
---|
Peter Swallow speeches from: Public Spending: Inheritance
Peter Swallow contributed 1 speech (55 words) Monday 29th July 2024 - Commons Chamber HM Treasury |
Peter Swallow speeches from: Education and Opportunity
Peter Swallow contributed 1 speech (1,129 words) Wednesday 24th July 2024 - Commons Chamber Department for International Development |
Peter Swallow speeches from: NATO and European Political Community Meetings
Peter Swallow contributed 1 speech (69 words) Monday 22nd July 2024 - Commons Chamber Cabinet Office |
Peter Swallow speeches from: Clean Energy Superpower Mission
Peter Swallow contributed 1 speech (58 words) Thursday 18th July 2024 - Commons Chamber Department for Energy Security & Net Zero |
Written Answers |
---|
Tax Avoidance
Asked by: Peter Swallow (Labour - Bracknell) Monday 29th July 2024 Question to the HM Treasury: To ask the Chancellor of the Exchequer, whether she has (a) received representations from and (b) held discussions with campaigners on the loan charge. Answered by James Murray - Exchequer Secretary (HM Treasury) I know that the loan charge is a very important matter for many members and their constituents. Within my first two weeks in office, I had my first meeting with campaigners to discuss the loan charge. The Chancellor and I have been considering this matter since taking office and will provide an update in due course. |
Attention Deficit Hyperactivity Disorder: Drugs
Asked by: Peter Swallow (Labour - Bracknell) Wednesday 31st July 2024 Question to the Department of Health and Social Care: To ask the Secretary of State for Health and Social Care, what steps his Department is taking to help increase supplies of ADHD medication. Answered by Karin Smyth - Minister of State (Department of Health and Social Care) The Department has been working hard with industry to help resolve supply issues with some attention deficit hyperactivity disorder (ADHD) medicines, which are affecting the United Kingdom and other countries around the world. As a result of this intensive work, some issues have been resolved. Many strengths of lisdexamfetamine and all strengths of atomoxetine capsules and guanfacine prolonged-release tablets are now available. We are working to resolve medicine supply issues, where they remain, for some strengths of lisdexamfetamine and methylphenidate. These are anticipated to resolve by August and October 2024, respectively. We are asking suppliers to secure additional stocks, expedite deliveries where possible, and review plans to further build capacity to support continued growth in demand for the short and long-term. The Department has worked with specialist clinicians to develop management advice for National Health Service clinicians, to consider prescribing available alternative brands of methylphenidate prolonged release tablets. We would expect ADHD service providers and specialists to follow our guidance to offer rapid response to primary care teams seeking urgent advice for the management of patients, including those known to be at a higher risk of adverse impact because of these shortages. To aid ADHD service providers and prescribers further, we have widely disseminated our communications, and continually update a list of currently available and unavailable ADHD products on the Specialist Pharmacy Service website, helping ensure that those involved in the prescribing and dispensing of ADHD medications can make informed decisions with patients. Further information is available at the following link: https://www.sps.nhs.uk/articles/prescribing-available-medicines-to-treat-adhd/ |
Pancreatin
Asked by: Peter Swallow (Labour - Bracknell) Monday 5th August 2024 Question to the Department of Health and Social Care: To ask the Secretary of State for Health and Social Care, what recent assessment he has made of the adequacy of the availability of Creon to treat Type 2 diabetes. Answered by Karin Smyth - Minister of State (Department of Health and Social Care) The Department has been working with suppliers to address current supply issues with pancreatic enzyme replacement therapy (PERT), including Creon, used by patients with conditions such as type 2 diabetes, cystic fibrosis, and certain cancers, including pancreatic cancer. The supply issues are impacting countries throughout Europe and have been caused by the limited availability of raw ingredients and manufacturing capacity constraints. The Department is continuing to work with all suppliers of PERT to help resolve the supply issues in the short and longer term. This includes asking that they expedite deliveries, source stock from other markets, and increase production. We have issued comprehensive guidance to healthcare professionals about these supply issues, which provide advice on how to manage patients whilst there is disruption to supply. This guidance is being kept under review, and updates will be made as necessary. Serious Shortage Protocols are in place for Creon 10,000 and 25,000 capsules to limit prescriptions to one months’ supply, to allow demand management. We understand how distressing medicine supply issues can be. While we can’t always prevent supply issues from occurring, the Department has a range of well-established processes and tools to manage them when they arise, and help mitigate risks to patients. |
Early Day Motions Signed |
---|
Wednesday 17th July Peter Swallow signed this EDM on Monday 22nd July 2024 200th anniversary of the Royal National Lifeboat Institution 51 signatures (Most recent: 30 Jul 2024)Tabled by: Helena Dollimore (Labour (Co-op) - Hastings and Rye) That this House congratulates the Royal National Lifeboat Institution (RNLI) on its 200th anniversary of saving lives at sea; thanks all crew members who have risked their lives to save over 140,000 lives at sea; and pays tribute to all volunteers past and present who support this vital work. |
Parliamentary Debates |
---|
Education and Opportunity
125 speeches (45,348 words) Wednesday 24th July 2024 - Commons Chamber Department for International Development Mentions: 1: Al Carns (Lab - Birmingham Selly Oak) Friends the Members for Bracknell (Peter Swallow) and for Gravesham (Dr Sullivan) for their fantastic - Link to Speech |